Reference
[1]
Shi S,
Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in
Hospitalized Patients With COVID-19 in Wuhan, China[J]. JAMA
Cardiol, 2020.
[2] Zhou F, Yu T, Du R, et al. Clinical course and risk factors for
mortality of adult inpatients with COVID-19 in Wuhan, China: a
retrospective cohort study[J]. The Lancet,
2020,395(10229):1054-1062.
[3]
Galie
N, Humbert M, Vachiery J L, et al. [2015 ESC/ERS Guidelines for the
diagnosis and treatment of pulmonary hypertension][J]. Kardiol
Pol, 2015,73(12):1127-1206.
[4] Peiris J, Chu C M, Cheng V, et al. Clinical progression and
viral load in a community outbreak of coronavirus-associated SARS
pneumonia: a prospective study[J]. The Lancet,
2003,361(9371):1767-1772.
[5] Hong K H, Choi J P, Hong S H, et al. Predictors of mortality in
Middle East respiratory syndrome (MERS)[J]. Thorax,
2018,73(3):286-289.
[6]
Guo
T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes
of Patients With Coronavirus Disease 2019 (COVID-19) [J]. JAMA
Cardiol, 2020, [Epub ahead of print].
[7] Inciardi R M, Lupi L, Zaccone G, et al. Cardiac Involvement in a
Patient With Coronavirus Disease 2019 (COVID-19)[J]. JAMA Cardiol,
2020.
[8]
Huang
C, Wang Y, Li X, et al. Clinical features of patients infected with 2019
novel coronavirus in Wuhan, China[J]. The Lancet,
2020,395(10223):497-506.
[9] Madjid M, Vela D, Khalili-Tabrizi H, et al. Systemic infections
cause exaggerated local inflammation in atherosclerotic coronary
arteries: clues to the triggering effect of acute infections on acute
coronary syndromes[J]. Tex Heart Inst J, 2007,34(1):11-18.
[10]
Namendys-Silva
S, Santos-Martínez L, Pulido T, et al. Pulmonary Hypertension Associated
With Acute Respiratory Distress Syndrome[J]. Chest, 2013,144(4,
Supplement):376A.
[11] Squara P, Dhainaut J F, Artigas A, et al. Hemodynamic profile
in severe ARDS: results of the European Collaborative ARDS Study[J].
Intensive Care Med, 1998,24(10):1018-1028.
[12]
Osman
D, Monnet X, Castelain V, et al. Incidence and prognostic value of right
ventricular failure in acute respiratory distress syndrome[J].
Intensive Care Med, 2009,35(1):69-76.
[13] Li S S, Cheng C W, Fu C L, et al. Left ventricular performance
in patients with severe acute respiratory syndrome: a 30-day
echocardiographic follow-up study[J]. Circulation,
2003,108(15):1798-1803.
[14]
Peiris
JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a
community outbreak of coronavirus-associated SARS pneumonia: a
prospective study[J].Lancet, 2003,361(9371):1767-72.
Figure legend:
Figure1 .A female patient, 77years old, was admitted to WuHan
Lei Shen Shan hospital with fatigue and right abdominal pain for 30
days.Echocardiography showed that the left atrium was enlarged, the
movement of the ventricular wall decreased, and the left ventricular
systolic function decreased.
Figure2、3 . A male patient, 81 years old, was admitted to WuHan
Lei Shen Shan hospital with cough and chest stuffiness for 2
weeks.Echocardiography showed pericardial effusion (9mm behind the left
posterior wall of the left ventricle), mild tricuspid regurgitation,
maximum reflux pressure about 36mmHg, and
pulmonaryarterialsystolicpressure was estimated to be about
46mmHg,therefore this patient has mild pulmonary hypertension.
Figure 4 Dynamic changes of cardiac biomarkers during
hospitalization. Figure shows dynamic changes in high-sensitivity
cardiac troponin I (ng/ml)(A), Brain natriuretic peptide (pg/ml)(B),
Creatine kinase MB (C), Lactate dehydrogenase (U/L) (D), α -
hydroxybutyrate dehydrogenase(E).